Lundbeck builds out brain drug pipeline with $250M acquisition – BioPharma Dive

Lundbeck builds out brain drug pipeline with $250M acquisition – BioPharma Dive
Lundbeck builds out brain drug pipeline with $250M acquisition  BioPharma DiveLundbeck, a Danish company that makes neurology drugs, intends to grow its pipeline and U.S. footprint through the acquisition of Abide Therapeutics. For $250 ... read more
Source: Google NewsPublished on 2019-05-06